In 2006, Anne Wojcicki cofounded 23andMe to help people access, understand, and benefit from the human genome, and she now serves as the company’s CEO.

In this conversation, Wojcicki will discuss the evolving benefits of genomic science, including the company’s crowdsourced research platform. This platform has played a role in creating one of the largest COVID-19 research studies, exploring whether genetics plays a role in the severity or susceptibility to the virus, and is helping to drive the discovery of novel, genetically validated therapeutic targets to bring new medicines to patients.

Learn more about and RSVP for Benefitting from the Human Genome.